Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

Published: June 2016
No. of Pages: 110

Price

GlobalData's clinical trial report, "Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Reasons to buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Diabetic Peripheral Neuropathy Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Diabetic Peripheral Neuropathy 29
Jun 27, 2016: VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate, VM202, in Painful Diabetic Peripheral Neuropathy 29
May 16, 2016: BioNevia and NeuroMax Announce Completion of Enrollment in Phase 2b Clinical Trial of BNV-222 29
May 11, 2016: Maxwell Biotech Venture Fund's Portfolio Company NeuroMax Announce Completion of Enrollment in Phase 2b Clinical Trial of BNV-222 30
Clinical Trial Profile Snapshots 31
Appendix 107
Abbreviations 107
Definitions 107
Research Methodology 108
Secondary Research 108
About GlobalData 109
Contact Us 109
Disclaimer 109
Source 110

List of Tables

Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region, 2016* 6
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 108

Published By: GlobalData
Product Code: GlobalData34993

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

Global and United States Biotin In-Depth Research Report 2017-2022
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by c...
2017-2022 Global and Japan Biotin Market Analysis Report
The global Biotin market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million...
Global and Europe Biotin Market - Analysis and Outlook to 2022
This report presents a comprehensive overview of the Biotin market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, including its dynami...
Global Biotin Detailed Analysis Report 2017-2022
This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Biotin industry...
2017-2022 United States Intravenous Immunoglobulin Market Report (Status and Outlook)
"This report will be delivered in 2-3 business days after the order is placed." The Intravenous Immunoglobulin market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Ra...
2017-2022 Philippines Intravenous Immunoglobulin Market Report (Status and Outlook)
"This report will be delivered in 2-3 business days after the order is placed." The Intravenous Immunoglobulin market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate...
2017-2022 Malaysia Intravenous Immunoglobulin Market Report (Status and Outlook)
"This report will be delivered in 2-3 business days after the order is placed." The Intravenous Immunoglobulin market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) X...
2017-2022 Japan Intravenous Immunoglobulin Market Report (Status and Outlook)
"This report will be delivered in 2-3 business days after the order is placed." The Intravenous Immunoglobulin market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% ...
2017-2022 India Intravenous Immunoglobulin Market Report (Status and Outlook)
"This report will be delivered in 2-3 business days after the order is placed." The Intravenous Immunoglobulin market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% ...
2017-2022 Global Top Countries Intravenous Immunoglobulin Market Report
"This report will be delivered in 2-3 business days after the order is placed." The Global Intravenous Immunoglobulin market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% fr...

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option

Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: